ARCHIVES

Phase III Regorafenib Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Patients urge Medicare to allow an open formulary for cancer treatment.

October 15, 2004

Breast Density As Important As Age In Determining Risk

September 29, 2006

Pesticides Not Linked To High Rates Of Breast Cancer.

May 18, 2001

Formal Guidelines For Training Grants Developed By NCI

December 7, 1979

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

HHS Awards $85 Million For Research to Eliminate Health Disparities

November 15, 2002